Quick Links:
Back to Home Page Back to Warrant Sheets
Back to Expired Warrants
Address: 500 - 2941
Napperton Dr
Strathroy Ont
Canada N7G 3H8
Phone: 855 628 6337
Fax: 416 863 1515
Web Site: https://evecannabis.ca
Warrant Symbol -
EVE.WT
Number Trading - 20.9 million
Expiration Date -
September 12,
2022
Cusip - 29970Q 12 3
Exercise Price - $0.60
x 10 + 10 warrants
Warrants called to trade
news
Eve & Co. 1:10 share rollback
2020-12-29 15:06 MT -
Rollback
Pursuant to a resolution passed by
shareholders on June 25, 2020, the
company has consolidated its
capital on a one-new-for-10-old
basis. The name of the company has
not been changed.
Effective at the opening on Dec.
31, 2020, the common shares of Eve
& Co. Inc. will commence trading
on the TSX Venture Exchange on a
consolidated basis. The company is
classified as a pharmaceutical
manufacturer and distributor
company.
Postconsolidation
Capitalization: unlimited shares
with no par value, of which
28,786,717 shares are issued and
outstanding
Trading symbol: EVE (unchanged)
Cusip No.: 29970Q 20 6 (new)
Warrants
Trading symbol: EVE.WT (unchanged)
Cusip No.: 29970Q 12 3 (unchanged)
In order to obtain one
postconsolidated share, the holder
must exercise 10 warrants for an
aggregate price of $6 until
expiration.
© 2021 Canjex Publishing Ltd. All
rights reserved.
Eve & Co. warrants to trade
Sept. 12
2019-09-10 17:06 MT -
Warrants Called to Trade
Effective at the opening,
Thursday, Sept. 12, 2019, the
common share purchase warrants of
the company will commence trading
on the TSX Venture Exchange.
Capitalization: up to 20.9 million
warrants created and authorized,
of which 20.9 million are issued
and outstanding
Trading symbol: EVE.WT
Cusip No.: 29970Q 12 3
Each warrant entitles the holder
to purchase one common share of
the company at a price of 60 cents
per share until expiry, which is
two years following the closing
date.
© 2019 Canjex Publishing Ltd. All
rights reserved.